Ep190: Neil Kumar on Building a Rare Disease Drug Company
The Long Run with Luke Timmerman
00:00
Using debt financing and weathering the downturn
Neil discusses raising over $1 billion in debt pre-revenue, investor reactions, and how debt preserved runway.
Play episode from 50:35
Transcript
